Gelişmiş Arama

Basit öğe kaydını göster

dc.contributor.authorBakırhan, Nurgül Karadaş
dc.contributor.authorAkmeşe, Bediha
dc.contributor.authorGöver, Tuğçe
dc.contributor.authorImanzadeh, Hamideh
dc.contributor.authorÖzkan, Sibel Ayşıl
dc.date.accessioned2021-11-01T18:14:56Z
dc.date.available2021-11-01T18:14:56Z
dc.date.issued2019
dc.identifier.issn2630-6344
dc.identifier.urihttps://doi.org10.35333/jrp.2019.30
dc.identifier.urihttps://app.trdizin.gov.tr/makale/TXpRMU5qYzBOQT09
dc.identifier.urihttps://hdl.handle.net/11491/7597
dc.description.abstractThe degradation of daunorubicin (DNR), doxorubicin (DXR) and vincristine (VCR) as chemotherapeutic agents was investigated under stress conditions such as acidic and alkaline media, oxidation, photolytic and heating. The degradation pathway determined by high-performance liquid chromatography (HPLC). Daunorubicin, doxorubicin and vincristine completely disintegrated in the basic medium. It has been determined that these drugs are resistant to heat. Daunorubicin and doxorubicin are resistant to UV light. However, vincristine is not very stable such as the other two compounds against UV light. The kinetic and thermodynamic parameters of daunorubicin, doxorubicin and vincristine were investigated in neutral media with different temperatures by electrochemical technique. Enthalpy, entropy and Gibbs free energy parameters were investigated in pH 7.4 phosphate buffer (PB) solution due to stability of these drugs at this pH. The studied chemotherapeutic agents showed endothermic process on glassy carbon-based electrode surface. Daunorubicin, doxorubicin and vincristine showed strongly adsorption process in room temperature. However, it showed diffusion property from electrode to solution with increasing the temperature values.en_US
dc.language.isoengen_US
dc.relation.ispartofJournal of research in pharmacy (online)en_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subject[No Keywords]en_US
dc.titleDegradation studies and thermodynamic parameters in aqueous solution of chemotherapeutic agents: Daunorubicin, doxorubicin and vincristineen_US
dc.typearticleen_US
dc.department[Belirlenecek]en_US
dc.identifier.volume23en_US
dc.identifier.issue5en_US
dc.identifier.startpage822en_US
dc.identifier.endpage831en_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.department-tempSağlık Bilimleri Üniversitesi, Gülhane Eczacılık Fakültesi, Analitik Kimya Bölümü, İstanbul, Türkiye;Hitit Üniversitesi, Fen-Edebiyat Fakültesi, Kimya Bölümü, Çorum, Türkiye;Selçuk Üniversitesi, Eczacılık Fakültesi, Analitik Kimya Bölümü, Konya, Türkiye;Shahid Madani University, Faculty of Sciences, Kimya Bölümü, Tabriz, Iran;Ankara Üniversitesi, Eczacılık Fakültesi, Analitik Kimya Bölümü, Ankara,Türkiyeen_US
dc.contributor.institutionauthor[Belirlenecek]
dc.identifier.doi10.35333/jrp.2019.30
dc.description.wospublicationidWOS:000485773700007en_US
dc.description.scopuspublicationid2-s2.0-85072920795en_US


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster